Regulatory T cells and IL-10 levels are reduced in patients with vulnerable coronary plaques

scientific article published on 06 April 2012

Regulatory T cells and IL-10 levels are reduced in patients with vulnerable coronary plaques is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.ATHEROSCLEROSIS.2012.03.016
P698PubMed publication ID22575708

P50authorArnon AfekQ7046055
P2093author name stringJacob George
Gideon Charach
Ari Shamiss
Michael Jonas
Diego Medvedovsky
Shmuel Schwartzenberg
P433issue2
P304page(s)519-523
P577publication date2012-04-06
P1433published inAtherosclerosisQ4813570
P1476titleRegulatory T cells and IL-10 levels are reduced in patients with vulnerable coronary plaques
P478volume222

Reverse relations

cites work (P2860)
Q30417917Anti-inflammatory immune skewing is atheroprotective: Apoe−/−FcγRIIb−/− mice develop fibrous carotid plaques
Q38423257Atherosclerosis and the role of immune cells
Q35798763Biomarkers Related to Carotid Intima-Media Thickness and Plaques in Long-Term Survivors of Ischemic Stroke
Q34979474Decreased naive and increased memory CD4(+) T cells are associated with subclinical atherosclerosis: the multi-ethnic study of atherosclerosis
Q36428109Extracellular HSP27 acts as a signaling molecule to activate NF-κB in macrophages.
Q91894202Fimasartan reduces neointimal formation and inflammation after carotid arterial injury in apolipoprotein E knockout mice
Q37664079Functional and homeostatic defects of regulatory T cells in patients with coronary artery disease
Q91698469Interleukin-10 as a predictor of major adverse cardiovascular events in a racially and ethnically diverse population: Multi-Ethnic Study of Atherosclerosis
Q35123740Is atherosclerosis an autoimmune disease?
Q98200234New insights into immunomodulation via overexpressing lipoic acid synthase as a therapeutic potential to reduce atherosclerosis
Q55361326Paracrine effect of regulatory T cells promotes cardiomyocyte proliferation during pregnancy and after myocardial infarction.
Q36784716Prognostic performance of interleukin-10 in patients with chest pain and mild to moderate coronary artery lesions-an 8-year follow-up study
Q57069785Regulatory T Cells Promote Macrophage Efferocytosis during Inflammation Resolution
Q42577777Regulatory T cells and Atherosclerosis
Q50093330Regulatory T cells as a new therapeutic target for atherosclerosis.
Q38622693Regulatory T cells in cardiovascular diseases
Q35907898Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: a longitudinal study during atorvastatin treatment
Q90057047Sequential Surgical Procedures in Vascular Surgery Patients Are Associated With Perioperative Adverse Cardiac Events
Q37703419Serum Cytokine Profile in Relation to the Severity of Coronary Artery Disease
Q26738584Stabilization of high-risk plaques
Q43163335Staging lymphocyte presence in human atherosclerosis: a tale told by numbers
Q90590521T cell subsets and functions in atherosclerosis
Q37250335T helper cell polarization in healthy people: implications for cardiovascular disease
Q58914607T lymphocyte autoreactivity in inflammatory mechanisms regulating atherosclerosis
Q37071591The reduced soluble fibrinogen-like protein 2 and regulatory T cells in acute coronary syndrome
Q38270134Treating atherosclerosis with regulatory T cells
Q92287764[Immunity and inflammation in atherosclerosis]

Search more.